351 related articles for article (PubMed ID: 33929613)
1. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.
Soldan SS; Anderson EM; Frase DM; Zhang Y; Caruso LB; Wang Y; Deakyne JS; Gewurz BE; Tempera I; Lieberman PM; Messick TE
Gastric Cancer; 2021 Sep; 24(5):1076-1088. PubMed ID: 33929613
[TBL] [Abstract][Full Text] [Related]
2. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
[TBL] [Abstract][Full Text] [Related]
3. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of two Epstein-Barr virus-positive gastric cancer cell lines with epitheliotropic M81 strain undergoing distinct viral and altered cellular expression profiles.
Xu M; Zhang L; Feng J; Yang S; Wang Y; Wang Y; Chen M; Zhou L; Zhang J; Qin Q
J Med Virol; 2023 Jan; 95(1):e28387. PubMed ID: 36478267
[TBL] [Abstract][Full Text] [Related]
5. Activation of DNA methyltransferase 3a by Epstein-Barr nuclear antigen 1 in gastric carcinoma.
Song H; Zhang Y; Liu J; Liu W; Luo B
Dig Liver Dis; 2022 Jul; 54(7):973-983. PubMed ID: 34215536
[TBL] [Abstract][Full Text] [Related]
6. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth.
Messick TE; Smith GR; Soldan SS; McDonnell ME; Deakyne JS; Malecka KA; Tolvinski L; van den Heuvel APJ; Gu BW; Cassel JA; Tran DH; Wassermann BR; Zhang Y; Velvadapu V; Zartler ER; Busson P; Reitz AB; Lieberman PM
Sci Transl Med; 2019 Mar; 11(482):. PubMed ID: 30842315
[TBL] [Abstract][Full Text] [Related]
9. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of the viral episome is essential for the cell survival of an Epstein-Barr virus positive gastric carcinoma cell line.
Oh ST; Kim M; Lee SK
Arch Pharm Res; 2009 May; 32(5):729-36. PubMed ID: 19471888
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the Aurora kinase A and Epstein-Barr nuclear antigen 1 axis in Epstein Barr virus associated gastric cancer.
Varshney N; Murmu S; Baral B; Kashyap D; Singh S; Kandpal M; Bhandari V; Chaurasia A; Kumar S; Jha HC
Virology; 2023 Nov; 588():109901. PubMed ID: 37839162
[TBL] [Abstract][Full Text] [Related]
13. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.
Jiang L; Xie C; Lung HL; Lo KW; Law GL; Mak NK; Wong KL
Theranostics; 2018; 8(19):5307-5319. PubMed ID: 30555548
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China.
Liu S; Zhao Z; Han L; Liu S; Luo B
PLoS One; 2016; 11(2):e0148342. PubMed ID: 26859565
[TBL] [Abstract][Full Text] [Related]
16. Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.
Nakayama A; Abe H; Kunita A; Saito R; Kanda T; Yamashita H; Seto Y; Ishikawa S; Fukayama M
PLoS One; 2019; 14(1):e0211358. PubMed ID: 30695048
[TBL] [Abstract][Full Text] [Related]
17. EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls.
Monaco MCG; Soldan SS; Su C; Clauze A; Cooper JF; Patel RJ; Lu F; Hughes RJ; Messick TE; Andrada FC; Ohayon J; Lieberman PM; Jacobson S
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37562974
[TBL] [Abstract][Full Text] [Related]
18. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.
Shen CL; Huang WH; Hsu HJ; Yang JH; Peng CW
Antiviral Res; 2019 Apr; 164():123-130. PubMed ID: 30817940
[TBL] [Abstract][Full Text] [Related]
19. The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer.
Huang X; Zhang M; Zhang Z
Curr Cancer Drug Targets; 2024; 24(2):127-141. PubMed ID: 37183458
[TBL] [Abstract][Full Text] [Related]
20. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.
Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X
Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]